Page last updated: 2024-11-12

perylenetetracarboxylic diimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

perylenetetracarboxylic diimide: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14618068
SCHEMBL ID3438530
MeSH IDM0506644

Synonyms (17)

Synonym
SCHEMBL3438530
82953-57-9
n,n'-bis(2,6-diisopropylphenyl)-3,4,9,10-perylenetetracarboxylic diimide
B4268
perylene orange
mfcd28100818
7,18-bis[2,6-di(propan-2-yl)phenyl]-7,18-diazaheptacyclo[14.6.2.22,5.03,12.04,9.013,23.020,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone
n,n-bis(2,6-diisopropylphenyl)-3,4,9,10-perylenetetracarboxylic diimide
lumaogen f 40
7,18-bis[2,6-di(propan-2-yl)phenyl]-7,18-diazaheptacyclo[14.6.2.2^{2,5.0^{3,12.0^{4,9.0^{13,23.0^{20,24]hexacosa-1(23),2,4,9,11,13,15,20(24),21,25-decaene-6,8,17,19-tetrone
T71369
YSWG765
n,n'-bis(2,6-diisopropylphenyl)-3,4,9,10-perylenetetracarboxylicdiimide
perylenetetracarboxylic diimide
n,n'-bis(2,6-diisopropylphenyl)-3,4,9,10-
SY055468
2,9-bis(2,6-diisopropylphenyl)anthra[2,1,9-def:6,5,10-d inverted exclamation mark e inverted exclamation mark f inverted exclamation mark ]diisoquinoline-1,3,8,10(2h,9h)-tetraone
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (38.24)29.6817
2010's19 (55.88)24.3611
2020's2 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.54 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index27.15 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (97.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]